Hydroa vacciniforme and solar urticaria

Rattanavalai Nitiyarom; Chanisada Wongpraparut

doi:10.1016/j.det.2014.03.013

Hydroa vacciniforme and solar urticaria

Dermatol Clin. 2014 Jul;32(3):345-53, viii. doi: 10.1016/j.det.2014.03.013. Epub 2014 Apr 24.

Authors

Rattanavalai Nitiyarom¹, Chanisada Wongpraparut²

Affiliations

¹ Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok 10700, Thailand.
² Department of Dermatology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok 10700, Thailand. Electronic address: ctuchinda@yahoo.com.

PMID: 24891056
DOI: 10.1016/j.det.2014.03.013

Abstract

Hydroa vacciniforme (HV) and solar urticaria (SU) are uncommon immunologically mediated photodermatoses. HV occurs almost exclusively in children, usually beginning in childhood and remitting spontaneously by adolescence. Association with chronic Epstein-Barr virus infection has been reported in HV, which raises the possibility of lymphoproliferative disorders in these patients. SU is characterized by skin erythema, swelling, and whealing immediately after sun exposure. Although several treatment options are available, the management of both conditions remains a challenge.

Keywords: Epstein-Barr virus; Hydroa vacciniforme; Lymphoproliferative disorder; Photodermatoses; Photosensitivity; Phototherapy; Plasmapheresis; Solar urticaria.

Publication types

Review

MeSH terms

Global Health
Humans
Hydroa Vacciniforme* / diagnosis
Hydroa Vacciniforme* / epidemiology
Hydroa Vacciniforme* / therapy
Morbidity / trends
Primary Prevention / methods*
Protective Clothing
Sunscreening Agents / therapeutic use*
Ultraviolet Rays / adverse effects*

Substances

Sunscreening Agents